Abstract - European Medical Journal

This site is intended for healthcare professionals

Continue

Abstracts

Reproductive Health
2 Mins
8 Aug 2019

Low Serum βhCG Concentration on Outcome Day (Trigger Day +17) Identifies a Subgroup of Women at Risk of Poor Perinatal Outcome

Pregnancies following assisted reproduction are at higher risk of poorer perinatal outcome.1 Algorithms combining age and various maternal serum hormone…
Reproductive Health
2 Mins
8 Aug 2019

Anti-Müllerian Hormone as a Quantitative and Qualitative Marker of Euploid Blastocysts

Anti-Müllerian hormone (AMH) is widely used in clinical practice to predict the ovarian response after ovarian stimulation and is considered as valid…
Reproductive Health
2 Mins
8 Aug 2019

Single Nucleotide Variations of Mitotic Arrest Deficient 1 Like 1 (MAD1L1) and MAD2L1 Genes in Products of Conception with Aneuploidy

Miscarriage is a pregnancy loss before the 20th week of the gestation. At least 15% of the recognised pregnancies will be terminated by spontaneous…
Reproductive Health
2 Mins
8 Aug 2019

BESST, a Non-Invasive Computational Tool for Embryo Selection Using Mass Spectral Profiling of Embryo Culture Media

The current gold standard of embryo evaluation is based on morphology and morphokinetics, however there have been many efforts to design non-invasive…
Reproductive Health
1 Mins
8 Aug 2019

To Analyse the Incidence of Ectopic Pregnancy in Fresh Embryo Transfer Compared with Frozen-Thawed Embryo Cycles in a Tertiary Infertility Centre in India

In vitro fertilisation (IVF) is one of the major risk factors for an ectopic pregnancy (EP). Rates of EP in women undergoing IVF range from 2–5%…
Hematology
1 Mins
1 Aug 2019

Tagraxofusp is a Novel Targeted Therapy Directed to CD123

Blastic plasmocytoid dendritic cell neoplasm (BPDCN), a rare, highly aggressive haematologic malignancy, often with cutaneous and other extramedullary…
Hematology
1 Mins
1 Aug 2019

Post-Transplant Cyclophosphamide in HLA Matched and Haploidentical Transplant Recipients Receiving Myeloablative Timed Sequential Busulfan Conditioning Regimen: Results of a Phase II Study

The authors report a prospective Phase II trial to assess (a) if post-transplant cyclophosphamide (PTCy) could be safely incorporated in a timed…
Hematology
1 Mins
1 Aug 2019

Autologous Dendritic Cell Vaccination to Prevent Progression and Relapse in Multiple Myeloma

Data from the National Cancer Institute showed that 50% of myeloma patients survive past 5 years post-diagnosis. This is encouraging but also warns…
We’ve noticed you’re accessing
from North/South America.